NMR identification of endogenous metabolites interacting with fatted and non-fatted human serum albumin in blood plasma: Fatty acids influence the HSA-metabolite interaction

Journal of Magnetic Resonance

Volumn 228, Issue , 2013, Pages 81-94

  Jupin, Marc ^a   Michiels, Paul J ^b   Girard, Frederic C ^b   Spraul, Manfred ^c   Wijmenga, Sybren S ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b Spinnovation Analytical   (Netherlands)

^c BRUKER BIOSPIN GMBH   (Germany)

Author keywords

Albumin; Blood plasma; Fatty acids; Interactions; Metabolites; Metabolomics; NMR

Indexed keywords

ACID CONCENTRATIONS; ALBUMIN; BLOOD PLASMA; CARDIO-VASCULAR DISEASE; CLINICAL DIAGNOSTICS; ENDOGENOUS METABOLITES; EXOGENOUS METABOLITES; EXTRACT INFORMATIONS; FATTY ACIDS CONTENTS; FREE CONCENTRATION; HUMAN SERUM ALBUMINS; METABOLIC PROFILES; METABOLIC PROFILING; METABOLITE CONCENTRATIONS; METABOLOMICS; MULTIPLE BINDING SITES; ON-BODY; PLASMA PROTEIN; PROTEIN INTERACTION; RELATIVE CONCENTRATION; RESONANCE INTEGRAL; TECHNICAL DEVELOPMENT; WEAK BINDING;

BEAM PLASMA INTERACTIONS; BLOOD; CHEMICAL SHIFT; FATTY ACIDS; METABOLISM; METABOLITES; NUCLEAR MAGNETIC RESONANCE; PLASMAS; PROTEINS; ULTRAFILTRATION;

BIOMOLECULES;

FATTY ACID; PLASMA PROTEIN; SERUM ALBUMIN;

ARTICLE; HUMAN; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PLASMA; PROTEIN BINDING;

BLOOD PROTEINS; FATTY ACIDS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PLASMA; PROTEIN BINDING; SERUM ALBUMIN;

EID: 84874179671     PISSN: 10907807     EISSN: 10960856     Source Type: Journal    
DOI: 10.1016/j.jmr.2012.12.010     Document Type: Article

References (49)

1. W.B. Dunn Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy Chem. Soc. Rev. 40 1 2011 387 426
2. Psychogios, N., et al., 2011. The human serum metabolome. Plos One 6(2).
3. I. Bertini Evidence of different metabolic phenotypes in humans Proc. Natl. Acad. Sci. U.S.A. 105 5 2008 1420 1424
4. D.J. Grainger Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using H-1-NMR-based metabonomics Nat. Med. 8 12 2002 1439 1444
5. D.S. Wishart HMDB: a knowledgebase for the human metabolome Nucleic Acids Res. 37 2009 D603 D610
6. D.S. Wishart HMDB: the human metabolome database Nucleic Acids Res. 35 2007 D521 D526
7. A. Zhang Modern analytical techniques in metabolomics analysis Analyst 137 2012 293 300
8. M.P. Stoop Quantitative proteomics and metabolomics analysis of normal human cerebrospinal fluid samples Mol. Cell. Proteomics 9 9 2010 2063 2075
9. H.R. Tang Use of relaxation-edited one-dimensional and two dimensional nuclear magnetic resonance spectroscopy to improve detection of small metabolites in blood plasma Anal. Biochem. 325 2 2004 260 272
10. S. Tiziani Optimized metabolite extraction from blood serum for (1)H nuclear magnetic resonance spectroscopy Anal. Biochem. 377 1 2008 16 23
11. C. Daykin, R. Bro, and F. Wulfert Data handling for interactive metabolomics: tools for studying the dynamics of metabolome-macromolecule interactions Metabolomics 8 2012 52 63
12. J.K. Nicholson, and K.P. Gartland 1H NMR studies on protein binding of histidine, tyrosine and phenylalanine in blood plasma NMR Biomed. 2 2 1989 77 82
13. J.D. Bell NMR-invisible lactate in blood-plasma FEBS Lett. 235 1-2 1988 81 86
14. C.A. Daykin The comparison of plasma deproteinization methods for the detection of low-molecular-weight metabolites by (1)H nuclear magnetic resonance spectroscopy Anal. Biochem. 304 2 2002 220 230
15. S. Curry Lessons from the crystallographic analysis of small molecule binding to human serum albumin Drug Metab. Pharmacokinet. 24 4 2009 342 357
16. U. Kragh-Hansen Molecular aspects of ligand binding to serum albumin Pharmacol. Rev. 33 1 1981 17 53
17. M. Otagiri, U. Kragh-Hansen, and V.T.G. Chuang Practical aspects of the ligand-binding and enzymatic properties of human serum albumin Biol. Pharm. Bull. 25 6 2002 695 704
18. B. Meloun, L. Moravek, and V. Kostka Complete amino-acid sequence of human-serum albumin FEBS Lett. 58 1 1975 134 137
19. G.J. van der Vusse Albumin as fatty acid transporter Eur. J. Drug Metab. Pharmacokinet. 24 4 2009 300 307
20. S. Curry Beyond expansion: structural studies on the transport roles of human serum albumin Vox Sanguinis 83 2002 315 319
21. A. Sulkowska Competitive binding of phenylbutazone and colchicine to serum albumin in multidrug therapy: a spectroscopic study J. Mol. Struct. 881 1-3 2008 97 106
22. V.T.G. Chuang, U. Kragh-Hansen, and M. Otagiri Pharmaceutical strategies utilizing recombinant human serum albumin Pharm. Res. 19 5 2002 569 577
23. A. Nakagawa O-2 binding properties of human serum albumin quadruple mutant complexed iron protoporphyrin IX with axial His-186 coordination Chem. Lett. 38 8 2009 776 777
24. A. Saifer, and L. Goldman Free fatty acids bound to human serum albumin J. Lipid Res. 2 3 1961 268
25. S. Curry, A.A. Bhattacharya, and T. Grune Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin J. Mol. Biol. 303 5 2000 721 732
26. S. Curry Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids J. Mol. Biol. 314 5 2001 955 960
27. T. Komatsu The role of an amino acid triad at the entrance of the heme pocket in human serum albumin for O-2 and CO binding to iron protoporphyrin IX Org. Biomol. Chem. 7 18 2009 3836 3841
28. J.R. Simard Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis J. Mol. Biol. 361 2 2006 336 351
29. M. Fasano Allosteric modulation of myristate and Mn(III)heme binding to human serum albumin FEBS J. 272 18 2005 4672 4683
30. P.J. Foxall 750 MHz 1H-NMR spectroscopy of human blood plasma J. Pharm. Biomed. Anal. 11 4-5 1993 267 276
31. J.K. Nicholson 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma Anal. Chem. 67 5 1995 793 811
32. J.D. Ashbrook, J.E. Fletcher, and A.A. Spector Medium chain fatty-acid binding to human plasma albumin J. Biol. Chem. 247 21 1972 7038
33. J.D. Ashbrook Long-chain fatty-acid binding to human plasma albumin J. Biol. Chem. 250 6 1975 2333 2338
34. D.S. Wishart Computational strategies for metabolite identification in metabolomics Bioanalysis 1 9 2009 1579 1596
35. D.S. Wishart Advances in metabolite identification Bioanalysis 3 15 2011 1769 1782
36. J.R. Sheedy A sample preparation protocol for H-1 nuclear magnetic resonance studies of water-soluble metabolites in blood and urine Anal. Biochem. 398 2 2010 263 265
37. C.N. Pace How to measure and predict the molar absorption-coefficient of a protein Protein Sci. 4 11 1995 2411 2423
38. S. Meiboom, and D. Gill Modified spin-echo method for measuring nuclear relaxation times Rev. Sci. Instrum. 29 8 1958 688 691
39. T.L. Hwang, and A.J. Shaka Water suppression that works-excitation sculpting using arbitrary wave-forms and pulsed-field gradients J. Magn. Reson. Ser. A 112 2 1995 275 279
40. N. Aranibar Metabolomic analysis using optimized NMR and statistical methods Anal. Biochem. 355 1 2006 62 70
41. J.G. Xia MetaboAnalyst: a web server for metabolomic data analysis and interpretation Nucleic Acids Res. 37 2009 W652 W660
42. A. Bax A spatially selective composite 90-degrees radiofrequency pulse J. Magn. Reson. 65 1 1985 142 145
43. J.G. Xia, and D.S. Wishart Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst Nat. Protocols 6 6 2011 743 760
44. L. Fielding NMR methods for the determination of protein-ligand dissociation constants Prog. Nucl. Magn. Reson. Spectrosc. 51 4 2007 219 242
45. M.L. Liu NMR spectroscopic diffusion, chemical shift and linewidth measurements of low-affinity binding of ibuprofen enantiomers to human serum albumin Magn. Reson. Chem. 37 4 1999 269 273
46. S. Goutelle The Hill equation: a review of its capabilities in pharmacological modelling Fundam. Clin. Pharmacol. 22 6 2008 633 648
47. J.N. Weiss The Hill equation revisited: uses and misuses FASEB J. 11 11 1997 835 841
48. J. Luo Protein-induced water H-1 MR frequency shifts: contributions from magnetic susceptibility and exchange effects J. Magn. Reson. 202 1 2010 102 108
49. P. Ascenzi The extraordinary ligand binding properties of human serum albumin IUBMB Life 57 12 2005 787 796